Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on July 7, 2005

Arteriosclerosis, Thrombosis, and Vascular Biology. 2005
Published online before print July 7, 2005, doi: 10.1161/01.ATV.0000176193.83629.c8
A more recent version of this article appeared on September 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/9/1767    most recent
01.ATV.0000176193.83629.c8v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimokawa, H.
Right arrow Articles by Takeshita, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimokawa, H.
Right arrow Articles by Takeshita, A.

Submitted on May 3, 2005
Accepted on June 24, 2005

Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine

Hiroaki Shimokawa * and Akira Takeshita

From the Department of Cardiovascular Medicine (H.S., A.T.) and the Kyushu University COE Program on Lifestyle-Related Diseases (H.S.), Kyushu University Graduate School of Medical Sciences, Fukuoka; and Japan Science and Technology Agency (H.S.), CREST, Tokyo, Japan.

Abstract--Rho-Kinase has been identified as one of the effectors of the small GTP-binding protein Rho. Accumulating evidence has demonstrated that Rho/Rho-kinase pathway plays an important role in various cellular functions, not only in vascular smooth muscle cell (VSMC) contraction but also in actin cytoskeleton organization, cell adhesion and motility, cytokinesis, and gene expressions, all of which may be involved in the pathogenesis of cardiovascular disease. At molecular level, Rho-kinase upregulates various molecules that accelerate inflammation/oxidative stress, thrombus formation, and fibrosis, whereas it downregulates endothelial nitric oxide synthase. The expression of Rho-kinase itself is mediated by protein kinase C/NF-{kappa}B pathway with an inhibitory and stimulatory modulation by estrogen and nicotine, respectively. At cellular level, Rho-kinase mediates VSMC hypercontraction, stimulates VSMC proliferation and migration, and enhances inflammatory cell motility. In animal studies, Rho-kinase has been shown to be substantially involved in the pathogenesis of vasospasm, arteriosclerosis, ischemia/reperfusion injury, hypertension, pulmonary hypertension, stroke and heart failure, and to enhance central sympathetic nerve activity. Finally, in clinical studies, fasudil, a Rho-kinase inhibitor, is effective for the treatment of a wide range of cardiovascular disease, including cerebral and coronary vasospasm, angina, hypertension, pulmonary hypertension, and heart failure, with a reasonable safety. Thus, Rho-kinase is an important therapeutic target in cardiovascular medicine.
Key words: cardiovascular disease • Rho • small G proteins • signal transduction • Rho-kinase




This article has been cited by other articles:


Home page
 Am. J. Physiol. Renal Physiol.Home page
V. Ramirez, J. Trujillo, R. Valdes, N. Uribe, C. Cruz, G. Gamba, and N. A. Bobadilla
Adrenalectomy prevents renal ischemia-reperfusion injury
Am J Physiol Renal Physiol, October 1, 2009; 297(4): F932 - F942.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Lohn, O. Plettenburg, Y. Ivashchenko, A. Kannt, A. Hofmeister, D. Kadereit, M. Schaefer, W. Linz, M. Kohlmann, J.-M. Herbert, et al.
Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor
Hypertension, September 1, 2009; 54(3): 676 - 683.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
N. N. Huynh, K. L. Andrews, G. A. Head, S. M.L. Khong, D. N. Mayorov, A. J. Murphy, G. Lambert, H. Kiriazis, Q. Xu, X.-J. Du, et al.
Arginase II Knockout Mouse Displays a Hypertensive Phenotype Despite a Decreased Vasoconstrictory Profile
Hypertension, August 1, 2009; 54(2): 294 - 301.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
H. Shimokawa and D. Heistad
Akira Takeshita, MD, PhD: 1940-2009
Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 787 - 788.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. K. Y. Chan, J. C. Mak, R. Y. K. Man, and P. M. Vanhoutte
Rho Kinase Inhibitors Prevent Endothelium-Dependent Contractions in the Rat Aorta
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 820 - 826.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Ying, P. Yue, X. Xu, M. Zhong, Q. Sun, M. Mikolaj, A. Wang, R. D. Brook, L. C. Chen, and S. Rajagopalan
Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1540 - H1550.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. Zhang, Q. Tang, F. Xu, Y. Xue, Z. Zhen, Y. Deng, M. Liu, J. Chen, S. Liu, M. Qiu, et al.
RhoA Regulates G1-S Progression of Gastric Cancer Cells by Modulation of Multiple INK4 Family Tumor Suppressors
Mol. Cancer Res., April 1, 2009; 7(4): 570 - 580.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. L. Neppl, L. T. Lubomirov, K. Momotani, G. Pfitzer, M. Eto, and A. V. Somlyo
Thromboxane A2-induced Bi-directional Regulation of Cerebral Arterial Tone
J. Biol. Chem., March 6, 2009; 284(10): 6348 - 6360.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
I. Kanazawa, T. Yamaguchi, S. Yano, M. Yamauchi, and T. Sugimoto
Activation of AMP kinase and inhibition of Rho kinase induce the mineralization of osteoblastic MC3T3-E1 cells through endothelial NOS and BMP-2 expression
Am J Physiol Endocrinol Metab, January 1, 2009; 296(1): E139 - E146.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. West, J. Harral, K. Lane, Y. Deng, B. Ickes, D. Crona, S. Albu, D. Stewart, and K. Fagan
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L744 - L755.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Gao, A. D. Portugal, J. Liu, S. Negash, W. Zhou, J. Tian, R. Xiang, L. D. Longo, and J. U. Raj
Preservation of cGMP-induced relaxation of pulmonary veins of fetal lambs exposed to chronic high altitude hypoxia: role of PKG and Rho kinase
Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L889 - L896.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
M. Zhang, R. Maddala, and P. V. Rao
Novel molecular insights into RhoA GTPase-induced resistance to aqueous humor outflow through the trabecular meshwork
Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1057 - C1070.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Q. Sun, P. Yue, Z. Ying, A. J. Cardounel, R. D. Brook, R. Devlin, J.-S. Hwang, J. L. Zweier, L. C. Chen, and S. Rajagopalan
Air Pollution Exposure Potentiates Hypertension Through Reactive Oxygen Species-Mediated Activation of Rho/ROCK
Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1760 - 1766.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
Y.-X. Qi, M.-J. Qu, D.-K. Long, B. Liu, Q.-P. Yao, S. Chien, and Z.-L. Jiang
Rho-GDP dissociation inhibitor alpha downregulated by low shear stress promotes vascular smooth muscle cell migration and apoptosis: a proteomic analysis
Cardiovasc Res, October 1, 2008; 80(1): 114 - 122.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Yasue, Y. Mizuno, E. Harada, T. Itoh, H. Nakagawa, M. Nakayama, H. Ogawa, S. Tayama, T. Honda, S. Hokimoto, et al.
Effects of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Fluvastatin, on Coronary Spasm After Withdrawal of Calcium-Channel Blockers
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1742 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. Phrommintikul, L. Tran, A. Kompa, B. Wang, A. Adrahtas, D. Cantwell, D. J. Kelly, and H. Krum
Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1804 - H1814.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
P. Rivera, M. P. Ocaranza, S. Lavandero, and J. E. Jalil
Rho Kinase Activation and Gene Expression Related to Vascular Remodeling in Normotensive Rats With High Angiotensin I Converting Enzyme Levels
Hypertension, October 1, 2007; 50(4): 792 - 798.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
D. W. Nuno, V. P. Korovkina, S. K. England, and K. G. Lamping
RhoA Activation Contributes to Sex Differences in Vascular Contractions
Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 1934 - 1940.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
V Haydont, C Bourgier, and M-C Vozenin-Brotons
Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicity
Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S32 - S40.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
G. P. van Nieuw Amerongen and V. W.M. van Hinsbergh
Endogenous RhoA Inhibitor Protects Endothelial Barrier
Circ. Res., July 6, 2007; 101(1): 7 - 9.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. A. Hamid, H. S. Bower, and G. F. Baxter
Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2598 - H2606.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
O. C. Manintveld, P. D. Verdouw, and D. J. Duncker
The RISK of ROCK
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2563 - H2565.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Oka, N. Homma, L. Taraseviciene-Stewart, K. G. Morris, D. Kraskauskas, N. Burns, N. F. Voelkel, and I. F. McMurtry
Rho Kinase-Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in Rats
Circ. Res., March 30, 2007; 100(6): 923 - 929.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Y. Gao, A. D. Portugal, S. Negash, W. Zhou, L. D. Longo, and J. Usha Raj
Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia
Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L678 - L684.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
A. Nohria, M. E. Grunert, Y. Rikitake, K. Noma, A. Prsic, P. Ganz, J. K. Liao, and M. A. Creager
Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease
Circ. Res., December 8, 2006; 99(12): 1426 - 1432.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Meyer-ter-Vehn, S. Sieprath, B. Katzenberger, S. Gebhardt, F. Grehn, and G. Schlunck
Contractility as a Prerequisite for TGF-{beta}-Induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4895 - 4904.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. Hizume, K. Morikawa, A. Takaki, K. Abe, K. Sunagawa, M. Amano, K. Kaibuchi, C. Kubo, and H. Shimokawa
Sustained Elevation of Serum Cortisol Level Causes Sensitization of Coronary Vasoconstricting Responses in Pigs In Vivo: A Possible Link Between Stress and Coronary Vasospasm
Circ. Res., September 29, 2006; 99(7): 767 - 775.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. M. G. Versteilen, I. J. M. Korstjens, R. J. P. Musters, A. B. J. Groeneveld, and P. Sipkema
Rho kinase regulates renal blood flow by modulating eNOS activity in ischemia-reperfusion of the rat kidney
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F606 - F611.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. Chrissobolis and C. G. Sobey
Recent Evidence for an Involvement of Rho-Kinase in Cerebral Vascular Disease
Stroke, August 1, 2006; 37(8): 2174 - 2180.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. Schubert
Sphingosine-1-phosphate in the circulatory system: Cause and therapeutic target for vascular dysfunction?
Cardiovasc Res, April 1, 2006; 70(1): 9 - 11.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
L. H. Romer, K. G. Birukov, and J. G.N. Garcia
Focal Adhesions: Paradigm for a Signaling Nexus
Circ. Res., March 17, 2006; 98(5): 606 - 616.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
T. Nagaoka, S. A. Gebb, V. Karoor, N. Homma, K. G. Morris, I. F. McMurtry, and M. Oka
Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat
J Appl Physiol, March 1, 2006; 100(3): 996 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. Noma, N. Oyama, and J. K. Liao
Physiological role of ROCKs in the cardiovascular system
Am J Physiol Cell Physiol, March 1, 2006; 290(3): C661 - C668.
[Abstract] [Full Text] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.